Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 8,847 shares at $48.47 ($419K) on 2016-02-01, disclosed to the SEC on 2016-02-03.
Open-market sale of $419k KITE by VP, Product Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.50 | 2,499 | $116K | 27.8% |
| 2 | $47.38 | 4,938 | $234K | 55.9% |
| 3 | $48.47 | 1,410 | $68K | 16.3% |
| Total | $47.31 avg | 8,847 | $419K | 100% |
| Filing → |
| KITE | SELL | 2016-01-05 | $547K | — | Filing → |
| KITE | SELL | 2016-01-05 | $554K | — | Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |